Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01727297 · ClinicalTrials.gov registry record · NA
REVEAL AF: Incidence of AF in High Risk Patients
A NA study, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- Completed
- Registry status
- NA
- Development phase
- 446
- Enrollment target
NCT01727297 is a NA study that has completed, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 446 participants.
The verdict
NCT01727297, a NA study, has completed, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- COMPLETED
- Registry status
- NA
- Development phase
- 446 participants
- Enrollment target
Study Summary
This study is to determine, through continuous monitoring with the Reveal implantable cardiac monitor (ICM), the incidence of atrial fibrillation (AF) in patients suspected to be at high risk for having AF and to understand how physicians manage these patients after AF has been detected. This study will also seek to identify what patient characteristics are most predictive of developing AF.
Interventions
- DEVICE REVEAL Implantable Cardiac Monitor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 446 participants |
| Start Date | 2012-11-13 |
| Est. Completion | 2017-01-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01727297
The ClinicalTrials.gov registry entry for NCT01727297 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 446 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Cardiac Rhythm and Heart Failure, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which REVEAL Implantable Cardiac Monitor is the first listed.
NCT01727297 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01727297 about?
NCT01727297 is a clinical study titled "REVEAL AF: Incidence of AF in High Risk Patients". This study is to determine, through continuous monitoring with the Reveal implantable cardiac monitor (ICM), the incidence of atrial fibrillation (AF) in patients suspected to be at high risk for having AF and to understand how physicians manage these patients after AF has been detected. This study ...
What is the current status of trial NCT01727297?
This trial is currently completed. It is a NA study. The enrollment target is 446 participants. The study started on 2012-11-13. Estimated completion is 2017-01-30.
What interventions are being tested in trial NCT01727297?
The interventions under investigation include: REVEAL Implantable Cardiac Monitor (DEVICE).
Who is sponsoring clinical trial NCT01727297?
This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.